Zeru Tian

1.2k total citations · 1 hit paper
19 papers, 913 citations indexed

About

Zeru Tian is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Zeru Tian has authored 19 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Zeru Tian's work include Advanced biosensing and bioanalysis techniques (4 papers), HER2/EGFR in Cancer Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Zeru Tian is often cited by papers focused on Advanced biosensing and bioanalysis techniques (4 papers), HER2/EGFR in Cancer Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Zeru Tian collaborates with scholars based in United States, China and Italy. Zeru Tian's co-authors include Yangyang Zhou, Jie Zhu, Qiang Cheng, Lan Lu, Mingxing Li, Wei Hu, Han Xiao, Yuda Chen, Sheng Lin and Chung‐Hang Leung and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Zeru Tian

19 papers receiving 908 citations

Hit Papers

Developing natural products as potential anti-biofilm agents 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeru Tian United States 13 564 144 138 122 109 19 913
L. Bekale Canada 18 536 1.0× 96 0.7× 127 0.9× 110 0.9× 68 0.6× 34 911
Rainer Riedl Switzerland 18 578 1.0× 121 0.8× 103 0.7× 255 2.1× 171 1.6× 49 1.2k
Elena A. Goun United States 17 1.0k 1.8× 260 1.8× 87 0.6× 191 1.6× 113 1.0× 26 1.4k
Faramarz Mehrnejad Iran 23 670 1.2× 125 0.9× 126 0.9× 101 0.8× 39 0.4× 73 1.1k
Bin Dong China 21 562 1.0× 166 1.2× 79 0.6× 64 0.5× 93 0.9× 70 1.1k
Pradeep Kumar Bolla United States 13 410 0.7× 153 1.1× 93 0.7× 48 0.4× 91 0.8× 24 1.0k
Daniel Agudelo Canada 21 1.1k 2.0× 180 1.3× 135 1.0× 205 1.7× 223 2.0× 32 1.6k
Omathanu Perumal United States 19 542 1.0× 175 1.2× 159 1.2× 121 1.0× 81 0.7× 29 1.4k
Héctor Quezada Mexico 16 719 1.3× 95 0.7× 101 0.7× 36 0.3× 55 0.5× 45 1.1k
Kaushik Kuche India 19 424 0.8× 267 1.9× 125 0.9× 72 0.6× 132 1.2× 41 1.1k

Countries citing papers authored by Zeru Tian

Since Specialization
Citations

This map shows the geographic impact of Zeru Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeru Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeru Tian more than expected).

Fields of papers citing papers by Zeru Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeru Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeru Tian. The network helps show where Zeru Tian may publish in the future.

Co-authorship network of co-authors of Zeru Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Zeru Tian. A scholar is included among the top collaborators of Zeru Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeru Tian. Zeru Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Guerrero, Erick, et al.. (2025). Investigating the functional contributions of phospholipids in selective organ targeting lipid nanoparticles. Biomaterials. 326. 123671–123671. 1 indexed citations
2.
Kim, Minjeong, Eunwoo Song, Joseph C. Chen, et al.. (2025). Dual SORT LNPs for multi-organ base editing. Nature Biotechnology. 6 indexed citations
3.
Wang, Yixian, Xia Meng, Zeru Tian, et al.. (2024). Engineering small-molecule and protein drugs for targeting bone tumors. Molecular Therapy. 32(5). 1219–1237. 12 indexed citations
4.
Khalid, Aysha B., et al.. (2024). KBTBD2 controls bone development by regulating IGF-1 signaling during osteoblast differentiation. Cell Death and Differentiation. 32(6). 1099–1111. 1 indexed citations
5.
Wu, Shiying, Yangyang Yang, Xizhen Lian, et al.. (2024). Isosteric 3D Bicyclo[1.1.1]Pentane (BCP) Core-Based Lipids for mRNA Delivery and CRISPR/Cas Gene Editing. Journal of the American Chemical Society. 146(50). 34733–34742. 4 indexed citations
6.
Álvarez‐Benedicto, Ester, Zeru Tian, Sumanta Chatterjee, et al.. (2023). Spleen SORT LNP Generated in situ CAR T Cells Extend Survival in a Mouse Model of Lymphoreplete B Cell Lymphoma. Angewandte Chemie International Edition. 62(44). e202310395–e202310395. 80 indexed citations
7.
Álvarez‐Benedicto, Ester, Zeru Tian, Sumanta Chatterjee, et al.. (2023). Spleen SORT LNP Generated in situ CAR T Cells Extend Survival in a Mouse Model of Lymphoreplete B Cell Lymphoma. Angewandte Chemie. 135(44). 12 indexed citations
8.
Chen, Yuda, Shikai Jin, Mengxi Zhang, et al.. (2022). Unleashing the potential of noncanonical amino acid biosynthesis to create cells with precision tyrosine sulfation. Nature Communications. 13(1). 5434–5434. 45 indexed citations
9.
Wang, Shichao, Hui Shi, Lushun Wang, et al.. (2022). Photostable Small-Molecule NIR-II Fluorescent Scaffolds that Cross the Blood–Brain Barrier for Noninvasive Brain Imaging. Journal of the American Chemical Society. 144(51). 23668–23676. 91 indexed citations
10.
Tian, Zeru, Chenfei Yu, Weijie Zhang, et al.. (2022). Bone-Specific Enhancement of Antibody Therapy for Breast Cancer Metastasis to Bone. ACS Central Science. 8(3). 312–321. 10 indexed citations
11.
Wang, Lushun, Shichao Wang, Juan Tang, et al.. (2021). Oxime as a general photocage for the design of visible light photo-activatable fluorophores. Chemical Science. 12(47). 15572–15580. 29 indexed citations
12.
Tian, Zeru, Ling Wu, Chenfei Yu, et al.. (2021). Harnessing the power of antibodies to fight bone metastasis. Science Advances. 7(26). 30 indexed citations
13.
Cao, Yu, Chenfei Yu, Kuan‐Lin Wu, et al.. (2021). Synthesis of precision antibody conjugates using proximity-induced chemistry. Theranostics. 11(18). 9107–9117. 30 indexed citations
14.
Cao, Yu, Chenfei Yu, Kuan‐Lin Wu, et al.. (2021). Synthesis of Precision Antibody Conjugates Using Proximity-Induced Chemistry. SSRN Electronic Journal. 2 indexed citations
15.
He, Yujing, et al.. (2020). Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer. Current Medicinal Chemistry. 28(9). 1775–1795. 22 indexed citations
16.
Chen, Yuda, Juan Tang, Lushun Wang, et al.. (2020). Creation of Bacterial Cells with 5-Hydroxytryptophan as a 21st Amino Acid Building Block. Chem. 6(10). 2717–2727. 45 indexed citations
17.
Lu, Lan, Wei Hu, Zeru Tian, et al.. (2019). Developing natural products as potential anti-biofilm agents. Chinese Medicine. 14(1). 11–11. 280 indexed citations breakdown →
18.
Lin, Sheng, Wei Gao, Zeru Tian, et al.. (2015). Luminescence switch-on detection of protein tyrosine kinase-7 using a G-quadruplex-selective probe. Chemical Science. 6(7). 4284–4290. 165 indexed citations
19.
Qi, Baohui, et al.. (2013). Discovery and optimization of novel 4-phenoxy-6,7-disubstituted quinolines possessing semicarbazones as c-Met kinase inhibitors. Bioorganic & Medicinal Chemistry. 21(17). 5246–5260. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026